Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Omeros Corporation - Common Stock
(NQ:
OMER
)
10.33
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,845
Open
10.33
Bid (Size)
9.800 (200)
Ask (Size)
10.20 (600)
Prev. Close
10.33
Today's Range
10.33 - 10.33
52wk Range
3.000 - 17.65
Shares Outstanding
62,855,824
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
July 06, 2026
From
The Schall Law Firm
Via
Business Wire
Performance
YTD
-36.9%
-36.9%
1 Month
+4.9%
+4.9%
3 Month
-5.9%
-5.9%
6 Month
-23.7%
-23.7%
1 Year
+235.4%
+235.4%
More News
Read More
Which stocks are moving on Friday?
↗
June 26, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Friday's session.
↗
June 26, 2026
Via
Chartmill
Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts
↗
May 13, 2026
Via
Chartmill
Omeros Corp (NASDAQ:OMER) Reports Q4 2025 Earnings Boosted by Major Asset Sale, Launches First Commercial Product
↗
March 31, 2026
Via
Chartmill
Top movers in Friday's pre-market session
↗
June 26, 2026
Via
Chartmill
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
June 26, 2026
From
Omeros Corporation
Via
Business Wire
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
↗
June 22, 2026
Via
The Motley Fool
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
↗
June 20, 2026
Via
The Motley Fool
Omeros Announces Webcast Details for Annual Meeting of Shareholders
June 15, 2026
From
Omeros Corporation
Via
Business Wire
Omeros (OMER) Q4 2025 Earnings Transcript
↗
June 01, 2026
Via
The Motley Fool
Topics
Derivatives
Omeros (OMER) Q1 2026 Earnings Transcript
↗
May 14, 2026
Via
The Motley Fool
Omeros Q1 Earnings Call Highlights
↗
May 14, 2026
Via
MarketBeat
Topics
Earnings
Omeros Corporation Reports First Quarter 2026 Financial Results
May 13, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
May 11, 2026
From
Omeros Corporation
Via
Business Wire
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
April 20, 2026
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
April 16, 2026
From
Omeros Corporation
Via
Business Wire
These stocks are gapping in today's session
↗
April 01, 2026
Via
Chartmill
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
March 31, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
March 26, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
March 21, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
February 17, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Announces First Commercial Sales of YARTEMLEA®
January 27, 2026
From
Omeros Corporation
Via
Business Wire
Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today
↗
January 08, 2026
Via
Stocktwits
Topics
ETFs
Government
Stocks
Frequently Asked Questions
Is Omeros Corporation - Common Stock publicly traded?
Yes, Omeros Corporation - Common Stock is publicly traded.
What exchange does Omeros Corporation - Common Stock trade on?
Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omeros Corporation - Common Stock?
The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
What is the current price of Omeros Corporation - Common Stock?
The current price of Omeros Corporation - Common Stock is 10.33
When was Omeros Corporation - Common Stock last traded?
The last trade of Omeros Corporation - Common Stock was at 07/07/26 04:00 PM ET
What is the market capitalization of Omeros Corporation - Common Stock?
The market capitalization of Omeros Corporation - Common Stock is 649.30M
How many shares of Omeros Corporation - Common Stock are outstanding?
Omeros Corporation - Common Stock has 649M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today